Citation Impact
Citing Papers
Complement and microglia mediate early synapse loss in Alzheimer mouse models
2016 StandoutScience
NSAID use and dementia risk in the Cardiovascular Health Study*
2007
Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice
2005
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Microglia as a Potential Bridge between the Amyloid β‐Peptide and Tau
2004
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
Inflammation and Alzheimer's disease
2000 Standout
Current Controlled Trials: an opportunity to help improve the quality of clinical research
2000
A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment
2005
Inflammatory processes in Alzheimer's disease
2007
Cognitive Enhancement Therapy for Alzheimerʼs Disease
1997
Apoptosis in the nervous system
2000 StandoutNature
Management of cancer pain
1999 Standout
Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
2011
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Oxidative Alterations in Alzheimer's Disease
1999
The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials
2001 Standout
The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease
2002
Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease
1999
Effect of a carboxy-terminal fragment of the alzheimer's amyloid precursor protein on expression of proinflammatory cytokines in rat glial cells
1997
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
1996
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease
1996
Nonsteroidal antiinflammatory drug use in Alzheimer's disease
1994
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
2007 Standout
NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies
2006
EVIDENCE FOR AN EARLY INFLAMMATORY RESPONSE IN THE CENTRAL NERVOUS SYSTEM OF MICE WITH SCRAPIE
1996
Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease
1998
Early laparoscopy versus active observation in acute abdominal pain: Systematic review and meta-analysis
2008
Alzheimer's disease
2011 Standout
Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches
1999
Induction of cyclooxygenase (COX)-2 but not COX-1 gene expression in apoptotic cell death
1998
Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E
1997 Nature
Mild Cognitive Impairment
2011 Standout
Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?
1995
Effects of stress throughout the lifespan on the brain, behaviour and cognition
2009 Standout
Molecular aspects of inflammatory and immune responses in Alzheimer's disease
1996
TGF‐β1 is an organizer of responses to neurodgeneration
1993
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
2001 Nature
Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures
1995
Cyclooxygenase and inflammation in Alzheimer's disease: Experimental approaches and clinical interventions
1998
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
1998 Standout
Modulation of Nuclear Factor-κB Activity by Indomethacin Influences Aβ Levels but Not Aβ Precursor Protein Metabolism in a Model of Alzheimer's Disease
2004
Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-β aggregation
2001
Inflammation and Alzheimer's disease pathogenesis
1996
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease
1996
The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research
2009
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
2012 StandoutNature
Structural and functional features of central nervous system lymphatic vessels
2015 StandoutNature
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Toll-Like Receptors in Alzheimer's Disease
2009
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Yin and Yang: complement activation and regulation in Alzheimer’s disease
2003
Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease
2007
Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo
2004 Standout
Increased Expression of Cyclooxygenases and Peroxisome Proliferator-Activated Receptor-γ in Alzheimer's Disease Brains
1999
Acute appendicitis: modern understanding of pathogenesis, diagnosis, and management
2015 Standout
Maturational Regulation and Regional Induction of Cyclooxygenase-2 in Rat Brain: Implications for Alzheimer's Disease
1997
Down Syndrome: Advances in Molecular Biology and the Neurosciences
2001
Neuronal Cyclooxygenase 2 Expression in the Hippocampal Formation as a Function of the Clinical Progression of Alzheimer Disease
2001
No Effect of One-Year Treatment with Indomethacin on Alzheimer's Disease Progression: A Randomized Controlled Trial
2008
The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alphal-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IκB-alpha
1999
Alzheimer's disease
2006 Standout
In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer’s brain using the positron emission tomography molecular imaging probe 2-(1-{6-[(2-[18F]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile
2003
Glucocorticoids in Alzheimer??s Disease
1998
Inhibition of Alzheimer's β-Amyloid Induced Vasoactivity and Proinflammatory Response in Microglia by a cGMP-Dependent Mechanism
1999
Role of microglia in senile plaque formation
1995
Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
2011 StandoutNobel
Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
1996 Standout
Cyclooxygenase and Alzheimer's disease: implications for preventive initiatives to slow the progression of clinical dementia
2001
Alzheimer's Disease
2010 Standout
Up-Regulated Production and Activation of the Complement System in Alzheimer's Disease Brain
1999
Inflammatory mechanisms in Alzheimer's disease
1994
The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases
1995
Priming of monocyte respiratory burst by β-amyloid fragment (25–35)
1996
Nonsteroidal anti-inflammatory drugs in Alzheimer's disease
1995
Down's syndrome
2003 Standout
Alzheimer's Disease
2004 Standout
BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain
2005 StandoutNature
Local Neuroinflammation and the Progression of Alzheimer's Disease
2002
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women
2003 Standout
Expression and regulation of complement C1q by human THP-1-derived macrophages
1998
Distinction Between Preclinical Alzheimer's Disease and Depression
2000
Anti-inflammatory Drugs Protect Against Alzheimer Disease at Low Doses
2000
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline
2007
COX-2 inhibitors
1999 Standout
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
2017 Standout
Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs
1999
Suppression of Aβ-induced monocyte neurotoxicity by antiinflammatory compounds
1997
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Molecular Mechanisms of Amyloidosis
2003 Standout
Indomethacin Reverses the Microglial Response to Amyloid β-Protein
1998
Alzheimer’s Disease And Inflammation: A Review Of Cellular And Therapeutic Mechanisms
2000
Assessment of Neuroinflammation and Microglial Activation in Alzheimer’s Disease with Radiolabelled PK11195 and Single Photon Emission Computed Tomography
2003
Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS
1999
NSAIDS inhibit the IL-1β-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2
1997
Cyclo-Oxygenase-2 Inhibitors
2000
RAGE Mediates a Novel Proinflammatory Axis
1999 Standout
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
2003
Anti-inflammatory substances – a new therapeutic option in Alzheimer's disease
1999
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
2005 Standout
Protective effects of NSAIDs on the development of Alzheimer disease
2008
Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.
2000
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
2002 StandoutScience
Common Pathological Processes and Transcriptional Pathways in Alzheimer's Disease and Type 2 Diabetes
2009
COX-2 and Alzheimer’s disease: potential roles in inflammation and neurodegeneration
1999
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
β-Amyloid Stimulation of Microglia and Monocytes Results in TNFα-Dependent Expression of Inducible Nitric Oxide Synthase and Neuronal Apoptosis
2001
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
1998 Standout
The effects of a novel NSAID on chronic neuroinflammation are age dependent☆
1999
Cyclooxygenase‐independent actions of cyclooxygenase inhibitors
2001
A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer’s disease
1999
Activated microglia in dementia with Lewy bodies
2000
Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats
1999
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging
1998
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
2001 Standout
MICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASES
1999
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
2003 StandoutScience
Alzheimer's Disease: Genes, Proteins, and Therapy
2001 Standout
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Reduced incidence of AD with NSAID but not H2receptor antagonists
2002
Modulation of β‐amyloid metabolism by non‐steroidal anti‐inflammatory drugs in neuronal cell cultures
2003
Are NSAIDs useful to treat Alzheimer’s disease or mild cognitive impairment?
2010
Monthly Update: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Neuroinflammatory mechanisms in Alzheimer's disease: new opportunities for drug discovery
1996
CYCLOOXYGENASES 1 AND 2
1998 StandoutNobel
Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT)
2008
Physical Activity and Public Health in Older Adults
2007 Standout
Inflammatory mechanisms in Alzheimer's disease: implications for therapy
1994
THE ROLE OF ANTI-INFLAMMATORY DRUGS IN THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE
1996
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
2003
Oxidative stress and neuroinflammation in Alzheimer's disease and amyotrophic lateral sclerosis: Common links and potential therapeutic targets
2004
Non-Steroidal Anti-Inflammatory Drug (NSAID) Use and Alzheimer Disease in Community-Dwelling Elderly Patients
2003
Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
2016
A randomized controlled trial of prednisone in Alzheimer’s disease
2000
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
1996 StandoutNature
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
The neural mechanisms underlying cholinergic celldeath within the basal FOREBRAIN
1998
Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease
2012
Microglial Activation and β-Amyloid Deposit Reduction Caused by a Nitric Oxide-Releasing Nonsteroidal Anti-Inflammatory Drug in Amyloid Precursor Protein Plus Presenilin-1 Transgenic Mice
2002
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.
2003
Rofecoxib
2004
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
2006 Standout
Works of P. D. Willson being referenced
Early laparoscopy as a routine procedure in the management of acute abdominal pain: a review of 1,320 patients
2005
Clinical trial of indomethacin in Alzheimer's disease
1993